Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence

G. Barbara*, L. Buggio, Federica Facchin, P. Vercellini

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Endometriosis is associated with painful symptoms, infertility, sexological difficulties, and psychological suffering. All these symptoms have a negative impact on the overall quality of life of women with the disease, with significant personal, social and economic costs. Several medical options are available to manage symptomatic endometriosis. The pharmacological treatment for endometriosis-related pain may be necessary for decades, or at least until there is a desire for pregnancy or physiologic menopause occurs. In this perspective, clinicians should consider not only the efficacy, but also side effects, tolerability, and costs, along with women's preferences toward different treatments. In this mini-review, we analyzed the pros and cons of the available drugs for the medical therapy of endometriosis, such as estrogen-progestins, progestins, GnRH agonist and GnRH antagonists.
Lingua originaleInglese
pagine (da-a)1-6
Numero di pagine6
RivistaFrontiers in Global Women's Health
Volume2
Numero di pubblicazioneSettembre
DOI
Stato di pubblicazionePubblicato - 2021

All Science Journal Classification (ASJC) codes

  • Medicina Generale

Keywords

  • GnRH agonists
  • GnRH antagonists
  • endometriosis
  • estrogen-progestins
  • medical treatment
  • quality of life
  • tolerability

Fingerprint

Entra nei temi di ricerca di 'Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence'. Insieme formano una fingerprint unica.

Cita questo